Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

40230318504_a38a3dbfde_z

Ambien and other insomnia meds to be labelled with black box warnings after sleepwalking deaths

May 2, 2019 Medical Communications, Research and Development FDA, ambien, black box warning, insomnia, sleeping pills, warning label

The FDA has said that Ambien, and other insomnia medications, must be labelled with a ‘black box warning’ – the …
News
robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …
News

The price of access: Can the NHS afford Orkambi?

April 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, NHS, NICE, Orkambi, UK, Vertex, access, cystic fibrosis, feature, pharma, pricing

The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …
Feature
gilead-sciences

Gilead’s selonsertib crashes at Phase 3 in NASH

April 26, 2019 Medical Communications, Research and Development, Sales and Marketing Gilead, nash, pharma, selonsertib

Gilead has broken the news that its apoptosis signal-regulating kinase 1 (ASK1) inhibitor selonsertib failed to meet its primary endpoint …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aduro Biotech, Cancer, GSK, ICR, J&J, JJ, Novartis, Sandoz, pharma

The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …
News
richard_saynor

Senior GSK exec Richard Saynor revealed as new Sandoz CEO

April 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …
Appointment
lilly_building_with_american_flag_web

Eli Lilly to withdraw Lartruvo from market in soft tissue sarcoma following Phase 3 failure

April 26, 2019 Medical Communications, Sales and Marketing Cancer, Eli Lilly, Lartruvo, pharma, soft tissue sarcoma

Eli Lilly has revealed it is to withdraw its platelet-derived growth factor receptor alpha (PDGFR-α) blocking antibody Lartruvo (olaratumab) from …
News
bug_plants_insect_leaf_nature_macrophotography_naturephotography_macro-1046343

Funding to fight malaria falls $2 billion short of WHO target, study shows

April 26, 2019 Medical Communications WHO, developing countires, funding, health economics, infectious diseases, malaria

Global spending on the fight against malaria has stalled, falling $2 billion short of World Health Organization (WHO) targets, according …
News
cancer-cells-541954_960_720

Researchers find Achilles’ heel protein in leukaemia

April 26, 2019 Medical Communications AML, Edinburgh, Protein, YTHDF2, blood cancer, drug targets, leukaemia

An international team of researchers have identified an “Achilles’ heel” protein that could lead to the development of novel treatments …
News

Pharmacists should review care homes residents’ medicine regimens to reduce polypharmacy

April 25, 2019 Medical Communications care homes, older people, pharmacists, pharmacy, polypharmacy

Pharmacists should review older people’s medicines regimens in order to reduce inappropriate polypharmacy, according to the Royal Pharmaceutical Society (RPS). …
News

ICR calls for faster access to innovative cancer drugs

April 25, 2019 Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, R&D, access, cancer drugs, incentives, innovation, oncology, pricing

The Institute of Cancer Research (ICR) has called for faster access to innovative cancer drugs in the UK. The call …
News

Interactions with the Agencies During Drug Development

April 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, NDA, drug development

 NDA would like to invite you to join  Professor Steffen Thirstrup, Director NDA Advisory Board, formerly Division Head at the Danish Medicines …
News
Press release
richard_saynor

Senior GSK exec Richard Saynor revealed as new Sandoz CEO

April 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sandoz, appointment, pharma

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …
News

Working Life: Dr Todd Hobbs, Vice President and Chief Medical Officer, Novo Nordisk

April 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Working Life, feature, pharma

Novo Nordisk’s VP and CMO discusses his leap from family medicine into the pharma industry, his biggest achievements, and how …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Genentech, Gilead, HIV, MS, Novartis, kidney disease, pharma

This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025